Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1998-07-09
2000-09-26
Azpuru, Carlos A.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424499, 424501, 424502, A61F 202, A61F 950
Patent
active
061239569
ABSTRACT:
A method for universally distributing a therapeutic agent, in an encapsulated form, to the brain of a subject using intrathecal administration, excluding the lumbar region, is described. Methods for treating stroke and/or Traumatic Brain Injury (TBI) are also described. The methods involve intrathecal administration into the cerebrospinal fluid of a subject, of a therapeutic agent in an encapsulated form. Pharmaceutical compositions intended for the amelioration of stroke and/or Traumatic Brain Injury (TBI) are also described. The pharmaceutical compositions comprise a therapeutic agent encapsulated in a pharmaceutically acceptable polymer, suitable for injection into the cerebrospinal fluid of a subject suffering from stroke and/or Traumatic Brain Injury (TBI).
REFERENCES:
patent: 4078052 (1978-03-01), Papahadjopoulos
patent: 4089801 (1978-05-01), Schneider
patent: 4145410 (1979-03-01), Sears
patent: 4224179 (1980-09-01), Schneider
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4310506 (1982-01-01), Baldeschwieler et al.
patent: 4394372 (1983-07-01), Taylor
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4599227 (1986-07-01), Dees et al.
patent: 4610868 (1986-09-01), Fountain et al.
patent: 4619913 (1986-10-01), Luck et al.
patent: 4752425 (1988-06-01), Martin et al.
patent: 4769250 (1988-09-01), Forssen
patent: 4781871 (1988-11-01), West, III et al.
patent: 4813399 (1989-03-01), Gordon
patent: 4833148 (1989-05-01), Olney
patent: 4837218 (1989-06-01), Olney
patent: 4861627 (1989-08-01), Mathiowitz et al.
patent: 4883666 (1989-11-01), Sabel et al.
patent: 4898734 (1990-02-01), Mathiowitz et al.
patent: 4906637 (1990-03-01), Faden
patent: 4920016 (1990-04-01), Allen et al.
patent: 4945097 (1990-07-01), Olney
patent: 4978668 (1990-12-01), Babbs et al.
patent: 5000959 (1991-03-01), Iga et al.
patent: 5010197 (1991-04-01), Ron et al.
patent: 5021200 (1991-06-01), Vanlerberghe et al.
patent: 5025032 (1991-06-01), Carney et al.
patent: 5055470 (1991-10-01), Boissard et al.
patent: 5057494 (1991-10-01), Sheffield
patent: 5077056 (1991-12-01), Bally et al.
patent: 5204112 (1993-04-01), Hope et al.
patent: 5208021 (1993-05-01), Johnson et al.
patent: 5211955 (1993-05-01), Legros et al.
patent: 5225212 (1993-07-01), Martin et al.
patent: 5258453 (1993-11-01), Kopecek et al.
patent: 5330768 (1994-07-01), Park et al.
patent: 5336493 (1994-08-01), Poznansky et al.
patent: 5342940 (1994-08-01), Ono et al.
patent: 5360610 (1994-11-01), Tice et al.
patent: 5395822 (1995-03-01), Izumi et al.
patent: 5401755 (1995-03-01), Rice et al.
patent: 5455044 (1995-10-01), Kim et al.
patent: 5487897 (1996-01-01), Polson et al.
patent: 5527822 (1996-06-01), Scheiner
patent: 5554767 (1996-09-01), Wang et al.
patent: 5576018 (1996-11-01), Kim et al.
patent: 5601835 (1997-02-01), Sabel et al.
Boer, G.J., et al., (1984) "Successful ventricular application of the miniaturized controlled-delivery Accurel technique for sustained enhancement of cerebrospinal fluid peptide leves in the rat", Journal of Neuoscience Methods, vol. 11, pp. 281-289;.
Chan, P.H., et al., (1987) "Protective Effects of Liposome-Entrapped Superoxide Dismutase on Posttraumatic Brain Edema", Annals of Neurology, vol. 21(6), pp. 540-547;.
Freeman, A.I. et al., (1986) "Targeted Drug Delivery", Cancer, vol. 58, pp. 573-583;.
Fresta, M et al., (1994) "Liposomes as In-vivo Carriers for Citicoline: Effects on Rat Cerebral Post-ischaemic Reperfusion", J. Pharm. Pharmacol., vol. 46, pp. 974-981;.
Gombotz, W.R., et al., (1995) "Bioderadable Polymers for Protein and Peptide Drug Delivery", Bioconjugate Chem, vol. 6, pp. 332-351;.
Jalsenjak, et al., (1988) "Development of biodegradable microcapsules for controlled drug release release into the brain", Acta. Pharm. Jugosl., vol. 38(4), pp. 297-305;.
Lazorthes, Y. et al., (1991) "Advances in Drug Delivery Systems and Applications in Neurosurgery", Adv Tech Stand Neurosung, vol. 18, pp. 143-192;.
Muizelaar, P.J., et al., (1993) "Cerebral Ischemia-Reperfusijn Injury After Severe Head Injury and Its Possible treatment With Polyethyleneglycol-Superoxide Dismutase", Annals of Emergency Medicine, vol. 22(6), pp. 1014-1021;.
Myseros J.S., et al., (1995) "The Rationale for Glutamate Antagonists in the Treatment of Traumatic Brain Injury", Annals New York Academy of Sciences, vol. 765, pp. 262-271;.
Streit, W.J., et al., (1995) "The Brain's Immune System", Scientific American, vol. 273, pp. 54-61;.
Ommaya, A.L., (1984) "Implantable Devices for Chronic Access and Drug Delivery to the Central Nervous System", Cancer Durg Delivery, vol. 1(2), pp. 169-179;.
Baker Keith
Kieras Mark
Pratt Daniel
Redmon Martin
Azpuru Carlos A.
Baker Keith
Hanley Elizabeth A.
LandOfFree
Methods for universally distributing therapeutic agents to the b does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for universally distributing therapeutic agents to the b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for universally distributing therapeutic agents to the b will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2097651